Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
1.
J Am Pharm Assoc (2003) ; 60(2): 344-351.e2, 2020.
Article in English | MEDLINE | ID: mdl-31735650

ABSTRACT

OBJECTIVES: Pharmacy personnel need practical strategies to incorporate nonseasonal vaccination services into pharmacy workflow. The objective of this study was to evaluate participants' confidence, perceived barriers and facilitators, and perceived influence on decision-making related to immunization services before and after the We Immunize program to assess program effectiveness. DESIGN: Randomized controlled trial. SETTING AND PARTICIPANTS: A total of 62 pharmacist-technician pairs from community pharmacies in Alabama and California participated in the randomized controlled trial. All participants were offered a 1-hour live immunization update. Intervention participants were also offered a 2-hour enhanced training at the beginning of the study period and tailored monthly feedback for 6 months. OUTCOME MEASURES: A survey was administered at baseline and after the intervention. Likert-type scales were used to rank level of agreement and differences were analyzed using paired-sample t tests and 2-way mixed analysis of variance. RESULTS: Sixty-seven participants completed both baseline and postintervention surveys (37 intervention; 30 control). Within the intervention group, participants' confidence in determining pneumococcal vaccine appropriateness (P = 0.027), confidence in pneumococcal vaccine-related patient interactions (P = 0.041), perceived external support (P = 0.016), and perceived influence on immunization services (P < 0.001) significantly improved. No change was observed within the control group. Compared to control participants, intervention participants showed a greater degree of change in perceived external support (P = 0.023) and influence on immunization services (P = 0.005) from baseline to post intervention. Neither confidence related to the herpes zoster vaccine nor marketing activities improved over the study period in either the intervention or control groups. CONCLUSION: Immunization training, including educational interventions and tailored feedback, can be used to positively impact pharmacy personnel's confidence in providing pneumococcal vaccinations and perceptions related to environmental support and influence on immunization services. This, in turn, may increase immunization activities within community settings.


Subject(s)
Community Pharmacy Services , Pharmacies , Pharmacy , Alabama , Humans , Immunization , Pharmacists , Vaccination
2.
Curr Pharm Teach Learn ; 11(4): 329-337, 2019 04.
Article in English | MEDLINE | ID: mdl-31040008

ABSTRACT

OBJECTIVE: To assess the sources of stress for pharmacy students and relationships to demographic factors and perceived stress. METHODS: Survey study of students at three pharmacy schools investigating student stress using the Perceived Stress Scale (PSS10), a two-tiered sources of stress questionnaire and demographic information. RESULTS: Student perceived stress levels were significantly higher than standard populations, but consistent with other pharmacy student populations. The strongest predictor of perceived stress was when students anticipated lower stress levels than actually experienced, followed by pressure to succeed. Additional variables were self-reported grade point average (GPA) and stress from relationships and experiential rotations. For first year (P1) students, having less than a bachelor's degree significantly influenced perceived stress. For the entire sample, male gender and health-related stress were significant. Academic performance (81%) and pressure to succeed (77%) were the most frequently reported general sources of stress. School B students were significantly less likely to report stress about postgraduate opportunities, career choices, and health issues. Students at school C were significantly less likely to report stress about academic issues. CONCLUSIONS: Pharmacy students' perceived stress is associated with their expectations, several general stressor categories, and demographic characteristics. Sources of stress appear to differ between pharmacy programs. Programs could examine their policies to see if there were more effective and timely means to address student stress. By better understanding the specific reasons for stress, we may be better able to mitigate its negative effects.


Subject(s)
Stress, Psychological/prevention & control , Students, Pharmacy/psychology , Academic Performance/psychology , Academic Performance/standards , Adult , Analysis of Variance , Education, Pharmacy, Graduate/methods , Education, Pharmacy, Graduate/standards , Education, Pharmacy, Graduate/trends , Educational Measurement/methods , Educational Measurement/standards , Female , Humans , Male , Psychometrics/instrumentation , Psychometrics/methods , Stress, Psychological/psychology , Students, Pharmacy/statistics & numerical data , Surveys and Questionnaires
3.
Res Social Adm Pharm ; 15(12): 1453-1463, 2019 12.
Article in English | MEDLINE | ID: mdl-30777645

ABSTRACT

BACKGROUND: The purpose of this study was to assess the impact of the We Immunize Program on structures, processes, and outcomes of pneumococcal and herpes zoster pharmacy-based immunization services. METHODS: Pharmacy-technician pairs from 62 Alabama and California community pharmacies participated in a 6-month randomized controlled trial (intervention = 30/control = 32). All received immunization update training; intervention participants also received practical strategies training and monthly telephonic expert feedback. Completion of immunization service structure and process activities were analyzed using Fisher's Exact and one-way Mann-Whitney U tests. The primary outcome, change in number of pneumococcal, herpes zoster, and total vaccine doses administered, was assessed using one-way Wilcoxon signed rank and Mann-Whitney U tests. Associations between program and vaccine doses across time were explored using generalized estimating equations (GEE). RESULTS: Intervention pharmacies completed more structure (median 12.00 versus 9.00, p = 0.200) and process activities (median 8.00 versus 7.00, p = 0.048) compared to control. Statistically significant increases in the median number of pneumococcal vaccine doses (7.50-12.00 doses, p = 0.007), and total vaccine doses (12.50-28.00 doses, p = 0.014) were seen from baseline to post-intervention within the intervention group. However, these changes were not statistically significant when compared to the control group (pneumococcal p = 0.136, total p = 0.202). Changes in median herpes zoster vaccine doses did not reach significance among intervention (8.50-9.00, p = 0.307) or control (9.00-13.00, p = 0.127) pharmacies. CONCLUSIONS: Practical strategies training combined with tailored expert feedback enhanced existing pneumococcal immunization services in community pharmacies. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT02615470.


Subject(s)
Community Pharmacy Services , Herpes Zoster Vaccine , Pneumococcal Vaccines , Vaccination/statistics & numerical data , Alabama , California , Female , Humans , Male , Pharmacy Technicians
4.
J Pharm Technol ; 35(5): 208-218, 2019 Oct.
Article in English | MEDLINE | ID: mdl-34752512

ABSTRACT

Background: Despite widely available nonseasonal immunization services in community pharmacies, actual pharmacist-administered vaccines are not yet optimal. A flexible choice multicomponent intervention, the "We Immunize" program, was implemented in Alabama and California community pharmacies, with the goal to enhance pneumococcal and zoster immunization delivery. Limited research has been done to qualitatively understand factors influencing immunization service expansion. Objective: Explore pharmacist perceptions of the We Immunize program in terms of its acceptability, impact, and real-world feasibility, and pharmacist-perceived facilitators and barriers influencing success in immunization delivery enhancement. Methods: This practice-focused qualitative research used semistructured telephone interviews with 14 pharmacists at the completion of the 6-month intervention. Results: Major program implementation facilitators were technician inclusion, workflow changes, training and feedback, goal setting, and enhanced personal selling and marketing activities. Multiple pharmacies increased the number of delivered pneumococcal and zoster immunizations, and increased revenue. Many pharmacists felt professional image, knowledge, skills, roles, and personal satisfaction were enhanced, as were technician knowledge, skills, and roles. Program flexibility, along with multiple perceived benefits, increases the potential for success. Conclusions: The We Immunize program appears to have been viewed positively by participating pharmacists and was seen as having a beneficial impact on immunization delivery in the community pharmacies in which it was implemented.

5.
Am J Pharm Educ ; 82(9): 6355, 2018 11.
Article in English | MEDLINE | ID: mdl-30559493

ABSTRACT

Objective. A five-factor measure was tested to see if it formed a single entrepreneurial drive scale, and which factors were associated with either general or pharmacy-specific entrepreneurial intention. Methods. Over three years, third-year Doctor of Pharmacy students completed a survey. Factor analysis, Cronbach's alpha, correlations, hierarchical regression analysis, and structural equations modeling were used to analyze the data. Results. There were 370 students out of 402 who participated. All five factors were identified, but not all proposed items were retained. Findings suggest that the five factors do not form a single entrepreneurial drive scale. Taking an entrepreneurship course and having a proactive disposition were significantly associated with both general and pharmacy-specific entrepreneurial intention. Female gender was significantly associated with lower general entrepreneurial intention. Conclusion. Proactive students should be recruited, and entrepreneurial courses offered.


Subject(s)
Students, Pharmacy/psychology , Achievement , Adult , Commerce , Education, Medical, Graduate , Education, Pharmacy , Entrepreneurship , Factor Analysis, Statistical , Female , Humans , Intention , Male , Motivation , Personality , Risk-Taking , Self Concept , Sex Factors , Surveys and Questionnaires
6.
Pediatr Diabetes ; 17(8): 623-631, 2016 12.
Article in English | MEDLINE | ID: mdl-26771087

ABSTRACT

Poor adherence to self-care among youth with type-1 diabetes (YWD) can lead to significant long-term health problems. Negative diabetes-related emotions (NDRE) are common, and are significantly correlated with poor/deteriorating A1c. Resilient youth handle diabetes self-care challenges, such as adjusting for diabetes in public, better. Resiliency skills and perceptions include benefit finding (BF), fitting in with friends (FI), diabetes acceptance (DA), emotion processing (EP) and emotion expression (EE). First study goal: to verify structure of underlying measurement variables: NDRE, EP, EE, BF, DA, FI and comfort in adjusting for diabetes in public (CA) among youth 11-16 yr of age with diabetes. We also hypothesize: (i) YWD who engage in EP and EE will have higher levels of BF, FI, DA, (ii) EP and EE will moderate NDRE impact and (iii) higher levels of EP, EE, BF, FI and DA will be associated with higher CA. SUBJECTS: 243 summer diabetes campers between 11-16 yr of age. METHODS: Pre-camp survey. RESULTS: Measurement variables were verified. EP and EE to friends were positively associated with BF, FI and DA for most YWD. NDRE was negatively associated with FI and DA, and for YWD aged 14-16 yr with CA. FI was positively associated with CA. EE moderated the impact of NDRE on CA among youth 11-13 yr. R2 for CA in youth 14-16 yr was 48.2%, for 11-13 yr was 38.3%. DA was positively associated with CA for youth 14-16 yr. CONCLUSIONS: Resilience factors appear to influence CA either directly or indirectly.


Subject(s)
Diabetes Mellitus, Type 1/psychology , Emotional Intelligence , Expressed Emotion , Resilience, Psychological , Adolescent , Age Factors , Child , Child, Preschool , Diabetes Mellitus, Type 1/blood , Diabetes Mellitus, Type 1/complications , Diabetes Mellitus, Type 1/therapy , Emotions , Female , Glycated Hemoglobin/analysis , Humans , Male , Quality of Life , Self Care , Surveys and Questionnaires
8.
Diabetes Technol Ther ; 17(3): 187-93, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25531555

ABSTRACT

BACKGROUND: Medication adherence can be affected by many factors, including health literacy. The purpose of this study is to determine (1) if a relationship exists between health literacy and self-reported or objectively measured medication adherence and (2) which aspect or aspects of medication nonadherence are most associated with health literacy. SUBJECTS AND METHODS: This is a multicenter, cross-sectional survey study of adult patients with type 2 diabetes mellitus (T2DM), taking one or more antidiabetes medication for ≥6 months with a hemoglobin A1c (HbA1c) measure on record. Data collected included patient demographics (age, gender, race, language, highest level of education, injectable diabetes medication use, last HbA1c, and diabetes medication refill history) and two survey instruments (the Morisky eight-item Medication Adherence Scale [MMAS-8] and the short-form Test of Functional Health Literacy in Adults [s-TOFHLA]). Descriptive statistics and bivariate correlations were assessed, along with linear and logistic regression. RESULTS: One hundred ninety-two patients with an average HbA1c level of 8.1% were included. Of these subjects, 32.8% had limited health literacy as measured by the s-TOFHLA, 58.9% had low adherence as measured by MMAS-8, and 65.1% were nonadherent based on cumulative medication gap (CMG) analysis. Age was associated with s-TOFHLA (-0.411; P<0.01) and MMAS-8 (0.157; P<0.05) scores. HbA1c was associated with MMAS-8 (-0.209; P<0.01) and CMG (0.152; P<0.05) scores. There was no significant association between s-TOFHLA and MMAS-8 or CMG. However, s-TOFHLA was positively related to MMAS-8 question 8, assessing difficulty remembering to take medications (P=0.017). CONCLUSIONS: Health literacy level is not associated with self-reported or objectively measured medication adherence in underserved patients with T2DM. Lower health literacy scores are associated with a patient experiencing difficulty remembering to take medications.


Subject(s)
Diabetes Mellitus, Type 2/drug therapy , Health Literacy/statistics & numerical data , Hypoglycemic Agents/administration & dosage , Medication Adherence/statistics & numerical data , Vulnerable Populations/psychology , Adult , Age Distribution , Aged , Aged, 80 and over , Cross-Sectional Studies , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/ethnology , Educational Status , Female , Glycated Hemoglobin/analysis , Humans , Language , Logistic Models , Male , Memory , Middle Aged , Multivariate Analysis , Self Report , Sex Distribution , Vulnerable Populations/statistics & numerical data
9.
J Genet Couns ; 23(2): 172-8, 2014 Apr.
Article in English | MEDLINE | ID: mdl-23846344

ABSTRACT

The purpose of this study was to assess consumer preferences for predictive genetic testing for Alzheimer disease in the United States. A rating conjoint analysis was conducted using an anonymous online survey distributed by Qualtrics to a general population panel in April 2011 in the United States. The study design included three attributes: Accuracy (40%, 80%, and 100%), Treatment Availability (Cure is available/Drug for symptom relief but no cure), and Anonymity (Anonymous/Not anonymous). A total of 12 scenarios were used to elicit people's preference, assessed by an 11-point scale. The respondents also indicated their highest willingness-to-pay (WTP) for each scenario through open-ended questions. A total of 295 responses were collected over 4 days. The most important attribute for the aggregate model was Accuracy, contributing 64.73% to the preference rating. Treatment Availability and Anonymity contributed 20.72% and 14.59%, respectively, to the preference rating. The median WTP for the highest-rating scenario (Accuracy 100%, a cure is available, test result is anonymous) was $100 (mean = $276). The median WTP for the lowest-rating scenario (40% accuracy, no cure but drugs for symptom relief, not anonymous) was zero (mean = $34). The results of this study highlight attributes people find important when making the hypothetical decision to obtain an AD genetic test. These results should be of interests to policy makers, genetic test developers and health care providers.


Subject(s)
Alzheimer Disease/diagnosis , Consumer Behavior , Genetic Predisposition to Disease , Adult , Alzheimer Disease/genetics , Female , Humans , Male , Middle Aged
10.
J Am Pharm Assoc (2003) ; 53(5): 466-74, 2013.
Article in English | MEDLINE | ID: mdl-24030123

ABSTRACT

OBJECTIVES: To determine whether perceived medication use knowledge held and/or needed influenced intention to seek information from pharmacists, whether an information-intention relationship held after accounting for other variables, and whether asking medication use knowledge questions increased pharmacist information-seeking intention. DESIGN: Cross-sectional study. SETTING United States during July 2012. PARTICIPANTS: Qualtrics national panel members 21 years or older obtaining a new chronic medication within previous 30 days. INTERVENTION: Internet-administered survey. MAIN OUTCOME MEASURES: Medication information-seeking intention, medication knowledge held and needed, and pharmacist medication information-seeking intention. RESULTS: Although knowledge held and needed were initially significant, they became nonsignificant after adding affective and evaluative attitudes, perceived control, and risk. The final best-fitting model explained 21% of variance in pharmacist information-seeking intention. Patient intentions to seek information from pharmacists increased significantly after being asked medication use knowledge questions. CONCLUSION: Perceptions of medication risk, attitudes, and information-seeking control predict pharmacist information-seeking intention and offer pharmacists an opportunity to market information services.


Subject(s)
Information Seeking Behavior , Patient Acceptance of Health Care/statistics & numerical data , Patient Education as Topic/methods , Pharmaceutical Services/organization & administration , Pharmacists/organization & administration , Adult , Cross-Sectional Studies , Data Collection , Female , Health Knowledge, Attitudes, Practice , Humans , Internet , Male , Middle Aged , United States
11.
Ther Innov Regul Sci ; 47(2): 183-189, 2013 Mar.
Article in English | MEDLINE | ID: mdl-30227527

ABSTRACT

The US FDA is proposing an expanded over-the-counter (OTC) medication policy to improve patient access to medications under the supervision of a pharmacist. Higher levels of medication access via multiple medication categories are common in other industrialized nations. Pharmacists are well trained and widely available. Expanding medication access can help alleviate the physician shortage by directing patients with appropriate health conditions that can be managed with medication to community pharmacists. Examples include migraine headaches and seasonal allergies, which have a significant impact on patients' quality of life and work productivity. Clinically relevant medications and dosages should be selected. Medication use guidelines should not be so restrictive as to defeat the policy intent. The proposed FDA policy is a long-overdue change that will help optimize available health personnel resources for patient care.

12.
J Am Pharm Assoc (2003) ; 51(1): 26-39, 2011.
Article in English | MEDLINE | ID: mdl-21247824

ABSTRACT

OBJECTIVE: To examine the issues surrounding the development and implementation of a behind-the-counter (BTC) category of medications. DATA SOURCES: Testimony from organizations submitting comments to the Food and Drug Administration (FDA) panel hearings in November 2007, the 2009 final report of the U. S. General Accounting Office regarding a BTC drug category, literature review of research that has been conducted, experiences from other countries, and publically available information from agencies in charge of regulating medications similar to BTC. SUMMARY: Based on evidence attained from the current work, the following six recommendations regarding a BTC category of medications are provided. (1) Demonstration needs to occur that the risks and/or costs of BTC are outweighed by benefits, positive measurable outcomes, and financial savings to society. (2) Sufficient resources, including personnel, equipment, and facilities, need to be available for the appropriate provision of BTC services and to ensure ongoing monitoring and controls. (3) An appropriate compensation structure needs to be developed. (4) Encounters and outcomes should be documented in an electronic record, the information should be shared with other health care providers involved in patients' care, and interprofessional collaboration and communication should occur. (5) Criteria for designating candidates for transition, ongoing review for safety, and reverse transition must be developed. (6) Applicable lessons learned from other countries should be incorporated into BTC strategies. In addition to implementation recommendations, we also summarize additional evidence that needs to be gathered to optimize the BTC model. CONCLUSION: Based on the accumulated evidence, comments to FDA's request, and information from other countries, implementation of a BTC model probably is feasible in the United States. However, the optimal model remains uncertain and various aspects of a program need to be prioritized and rigorously tested.


Subject(s)
Behind-the-Counter Drugs/adverse effects , Behind-the-Counter Drugs/therapeutic use , Humans , Risk Assessment , United States , United States Food and Drug Administration
13.
J Pediatr Pharmacol Ther ; 16(4): 270-80, 2011 Oct.
Article in English | MEDLINE | ID: mdl-22768011

ABSTRACT

OBJECTIVES: To qualitatively explore differences in Leventhal's common sense model (CSM) constructs between youth with type 1 diabetes (T1D) and sickle cell disease (SCD) and between different age groups and level of disease control. METHODS: Two structured individual interviews were conducted in 24 youth with T1D (n=12) or SCD (n=12). Patients were between 8 and 21 years of age, had either good or poor disease control, and were seen at an outpatient children's hospital medical clinic. RESULTS: YOUTH CONCEPTUALIZE THEIR CHRONIC DISEASE IN TERMS OF IDENTITY, CAUSE, TIMELINE, CONTROL, AND CONSEQUENCES: both cognitive and emotional dimensions are apparent. There was considerable contrast between discussions of youth with well- and poorly controlled T1D but little contrast between youth with well- and poorly controlled SCD. Surprisingly, youth with well-controlled T1D mentioned emotions most frequently. No youth with poorly controlled T1D described disease acceptance, but the majority of youth with well-controlled T1D did. Adolescents and young adults with good T1D control appear to understand disease cause, have better illness coherence, and habitually link discussion of symptoms and negative emotions with solutions. Youth with poorly controlled T1D appeared more likely to connect symptoms with negative consequences. Consequences included 1) disease symptoms, 2) the need to perform self-care activities, 3) physical outcomes, 4) health-system activities, 5) emotions, and 6) life impact. Interestingly, sickling crisis was mentioned more frequently by youth with good SCD control than by those with poor SCD control. Youth with SCD are distressed by others' judgmental perceptions and by feeling different from others. CONCLUSIONS: In contrast to previous CSM work, youth with well-controlled T1D in this study discussed emotions more frequently than did those with poor control. Disease perceptions were similar between youth with well- and poorly controlled SCD. Results indicate there are noteworthy cognitive and emotional differences between youth with different types of disease and levels of disease control.

14.
J Pediatr Pharmacol Ther ; 15(2): 126-37, 2010 Apr.
Article in English | MEDLINE | ID: mdl-22477803

ABSTRACT

BACKGROUND: Safety and efficacy issues regarding over-the-counter cough and cold (CAC) products for use in children have surfaced. Late in 2007 the FDA began reviewing CAC product status for use in children under 6 years old. OBJECTIVE: In regards to CAC products for children < 6 years old, to determine pharmacists: 1) comfort level in recommending; 2) attitudes towards behind-the-counter (BTC) status; and 3) level of support for BTC status. An additional objective was to determine how frequently pharmacists were asked for CAC product recommendations for children METHODS: Georgia Pharmacy Association members (2,045) were invited to anonymously participate in a self-administered online survey from January 3 - Feb 6, 2008. Topic areas included demographics, comfort in recommending CAC, and BTC status. RESULTS: Most responding pharmacists (99.1%) feel pediatric CAC medicine safety problems are due to inappropriate use. More than 50% of chain and independent pharmacists were asked to recommend CAC medicines for children during cold/flu season once a day or less, and 79% reported counseling on less than 50% of total CAC sales. The majority of pharmacists felt comfortable recommending CAC medications when thinking of both safety and efficacy. Most pharmacists supported a BTC condition of sale for children under two for decongestants, antihistamines, and antitussives, and for decongestants and antitussives for children between 2 and 5 years old. CONCLUSIONS: Most pharmacists indicate comfort in recommending CAC despite lack of evidence for safety or efficacy and support BTC status. Pharmacist education on this topic would be useful.

15.
Br J Health Psychol ; 15(Pt 2): 231-51, 2010 May.
Article in English | MEDLINE | ID: mdl-19594986

ABSTRACT

OBJECTIVES: Women reaching menopause must make a controversial decision about whether to use hormone therapy (HT). The theory of planned behaviour (TPB) was the organizing framework. The objectives were to determine if (1) influence of different TPB constructs varied with stage of menopause and HT use, (2) women with diabetes were influenced in significantly different ways from women without, (3) the overall perceived behavioural control (PBC) and self-efficacy (SE) have independent effects on intention, and (4) physician influence was mediated by subjective norm (SN). DESIGN: Cross-sectional survey of women from a managed care organization. METHODS: Multiple regression analysis was used to analyse 765 responses (230 from women with diabetes) and separately four main subgroups: (1) early menopause stage and never used HT, (2) late menopause stage and never used HT, (3) late menopause stage and previously used HT, and (4) late menopause stage currently using HT. RESULTS: For the entire sample, the model explains 68% of variance in intention, where SE, physicians' influence, self-identification with menopause as a natural part of ageing, self-identification as someone who wants to delay menopause, HT status, menopause status, and diabetes were added to the TPB. For the entire sample, SE added 2% to the explained variance and the physician determinant added 7%. CONCLUSIONS: An augmented TPB is useful for understanding women's HT use decisions. The theory explains more variance in intention before a behaviour is enacted than after, and decision structure changes over time. PBC and SE have independent effects on intention.


Subject(s)
Decision Making , Diabetes Mellitus, Type 2/psychology , Estrogen Replacement Therapy/psychology , Intention , Perimenopause/psychology , Cross-Sectional Studies , Female , Health Knowledge, Attitudes, Practice , Health Surveys , Humans , Internal-External Control , Middle Aged , Perimenopause/drug effects , Physician's Role/psychology , Self Efficacy , United States
16.
Womens Health Issues ; 19(2): 144-53, 2009.
Article in English | MEDLINE | ID: mdl-19272565

ABSTRACT

BACKGROUND: Frequent shifts in expert opinion over whether or not women should use hormone therapy (HT) or another menopausal treatment have left women in a difficult position; they must determine where they can obtain trustworthy menopause information. In this study, conducted 10-12 months after the Women's Health Initiative study first published results, we identified sources women use for information about menopause treatments, identified how trust-related dimensions (trustworthiness, knowledge, helpfulness, bias, and vested interest) influenced use of these sources, and determined how these trust dimensions varied with women's HT use status. METHODS: A total of 765 women >45 and <61 years of age from a Midwestern managed care organization responded to a survey. Trust dimensions regarding family, friends, physicians, pharmacists, other health care providers (HCP), and various media as sources of menopause information, and use of these sources for menopause information were examined. RESULTS: Women ranked physicians significantly higher than pharmacists and other HCP for trustworthiness, helpfulness, and knowledgeability. Perceived bias, knowledgeability, and helpfulness showed the strongest influence on trust in physician as well as nonpharmacist HCP. Menopause stage, HT use status, and helpfulness influenced use of physician for information. Helpfulness and knowledgeability influenced trust in the pharmacist, whereas actual use was predicated on having used HT, trust, and helpfulness. CONCLUSIONS: Women who had never used HT trusted HCP less. HCP have important roles in providing menopause information to perimenopausal women. HCP may need to reach out and initiate these important discussions with their patients.


Subject(s)
Estrogen Replacement Therapy/statistics & numerical data , Mass Media/statistics & numerical data , Menopause/psychology , Patient Education as Topic/statistics & numerical data , Trust , Women's Health , Female , Health Knowledge, Attitudes, Practice , Humans , Middle Aged , Patient Compliance , United States
17.
Res Social Adm Pharm ; 4(3): 186-205, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18794031

ABSTRACT

BACKGROUND: Focus groups are a powerful research tool for collecting qualitative information across many contexts. The focus group offers pharmacy researchers benefits that support many of the important lines of investigation at the forefront of contemporary pharmacy-based research, particularly within the areas of patient compliance/concordance, customer behavior, patient-provider collaboration, health literacy research, and disease management. This article introduces the focus group as a research method that offers powerful investigative potential to researchers who are attempting to understand human-based phenomena. OBJECTIVES: To provide sufficient background, examples, and how to information to enable a pharmacy researcher to include focus group methodologies in their initial design decisions, and provide guidance to additional resources necessary for successful implementation of this powerful qualitative approach. METHODS: The article is organized into sections describing what a focus group is and what it can be used for; the unique benefits and drawbacks of using focus group methodology; organization and planning considerations including participant and recruitment considerations; and sampling strategies, session and question development, practical details of session management, and follow-up activities, including data analysis. RESULTS/CONCLUSION: Although often considered quick and easy focus groups require thoughtful consideration of need and purpose, considerable planning, and effort to succeed. Because of the unique insight that can be gained, their flexibility, and their ability to mesh with other methods, focus group is gaining currency as an important research tool within health care.


Subject(s)
Focus Groups/methods , Pharmaceutical Services , Research Design , Decision Support Techniques , Humans , Patient Selection
18.
Am J Health Behav ; 31(2): 203-14, 2007.
Article in English | MEDLINE | ID: mdl-17269910

ABSTRACT

OBJECTIVE: To assess the theory of planned behavior (TPB) and TPB with functional ability to explain intention and self-reported physical activity (PA) behavior of older adults. METHODS: A survey was mailed to 2056 retirees from a large Midwestern university. RESULTS: Structural equation modeling revealed that the TPB plus functional ability explained an additional 11% variance than the TPB alone in older adult PA and functional ability was the best predictor of PA (beta = .53, P<.05). CONCLUSIONS: Functional ability appears to be an important predictor of PA behavior and should be included when designing PA programs for older adults.


Subject(s)
Exercise , Health Behavior , Motivation , Aged , Aged, 80 and over , Cross-Sectional Studies , Female , Humans , Intention , Male , Midwestern United States , Models, Theoretical
19.
Expert Opin Pharmacother ; 7(8): 989-1003, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16722810

ABSTRACT

Anticoagulants are used for the prevention and treatment of venous thromboembolism and for the secondary prevention of stroke and myocardial infarction. The list of available anticoagulants includes unfractionated heparin, low molecular weight heparins, fondaparinux, warfarin and the direct thrombin inhibitors. Numerous randomised controlled trials have pitted one anticoagulant against another to ascertain superiority in terms of safety and efficacy. Differences in these outcomes are assessed using appropriate statistical tests. When a statistically significant difference is found, it is generally accepted that one option is superior to another. There is also an interest in whether there is a clinically significant difference between two or more treatments, even when there may not be a statistically significant difference. This decision is reached through clinical judgment based on logical and ethical considerations. Another important way to judge the difference between alternative treatment strategies is to test for economically significant differences. This is accomplished through pharmacoeconomic analysis. This paper reviews the evidence gathered from published studies designed to detect an economically significant difference between two or more anticoagulants used for the same clinical indication.


Subject(s)
Anticoagulants/economics , Myocardial Ischemia/economics , Postoperative Complications/economics , Thromboembolism/economics , Venous Thrombosis/economics , Anticoagulants/therapeutic use , Cost-Benefit Analysis , Health Care Costs , Humans , Models, Economic , Myocardial Ischemia/drug therapy , Postoperative Complications/prevention & control , Practice Guidelines as Topic , Randomized Controlled Trials as Topic , Thromboembolism/drug therapy , Thromboembolism/prevention & control , Treatment Outcome , Venous Thrombosis/drug therapy , Venous Thrombosis/prevention & control
20.
Maturitas ; 55(1): 58-68, 2006 Aug 20.
Article in English | MEDLINE | ID: mdl-16504429

ABSTRACT

OBJECTIVES: (1) Describe women's (a) hormone replacement therapy (HRT) use patterns, (b) intentions to use or continue to use HRT among women in the early and late stages of menopause, and (c) beliefs about using HRT and (2) compare these beliefs, patterns, and intentions between women with and without diabetes 10-12 months after news from the women's health initiative was widely publicized. METHODS: A survey mailed to female enrollees of a not-for-profit managed care organization (MCO) between 46 and 60 years of age and with or without diabetes. Descriptive statistics were calculated. Chi-square analysis was used to determine significant differences between four different HRT use and menopause stage groups, (1) early stage never user, (2) late stage never user, (3) late stage current user, and (4) late stage previous user. Analysis of variance (ANOVA) was used to identify significant belief differences between the four groups. Repeated-measures ANOVA was performed to examine differences between women with and without diabetes. RESULTS: Most women did not intend to initiate HRT. About 86% of current HRT users intended to continue. Never users with diabetes were significantly more uncertain about HRT intention than non-diabetic women. All beliefs were significantly different (p<0.001) between the four groups, but not between women with and without diabetes. CONCLUSION: Women in different groups hold different beliefs about HRT use. Uncertainty among women with diabetes is not resolved as quickly as among women without diabetes.


Subject(s)
Cardiovascular Diseases/prevention & control , Diabetes Mellitus , Estrogen Replacement Therapy , Health Knowledge, Attitudes, Practice , Menopause , Female , Humans , Michigan/epidemiology , Middle Aged , Surveys and Questionnaires
SELECTION OF CITATIONS
SEARCH DETAIL
...